Dapagliflozin mitigates myocardial inflammation and metabolic stress in heart failure through STAT1 inhibition: Evidence from multi-omics analyses and experimental exploration

• Lianqi He,

  Roles Conceptualization, Data curation

  Affiliation Department of Cardiology, Central Hospital of Fushun, Fushun, Liaoning, China

  ⨯
• Di Zhang,

  Roles Formal analysis, Funding acquisition, Investigation

  Affiliation Department of Cardiology, Central Hospital of Fushun, Fushun, Liaoning, China

  ⨯
• Shiwen Zhang,

  Roles Methodology, Project administration, Resources

  Affiliation Department of Cardiology, Central Hospital of Fushun, Fushun, Liaoning, China

  ⨯
• Zhichao Ren,

  Roles Project administration, Resources, Software, Supervision

  Affiliation Department of Cardiology, Central Hospital of Fushun, Fushun, Liaoning, China

  ⨯
• Yihong Huangfu,

  Roles Validation, Visualization, Writing – original draft

  Affiliations Department of Cardiology, Central Hospital of Fushun, Fushun, Liaoning, China, Graduate School, Jinzhou Medical University, Jinzhou, Liaoning, China

  ⨯
• Xiran Cheng,

  Roles Resources, Supervision, Visualization

  Affiliation Changsha Medical College, Changsha, Hunan, China

  ⨯
• Zhanchun Song

  Roles Investigation, Resources, Writing – review & editing

  * E-mail: szcclszccl@163.com

  Affiliation Department of Cardiology, Central Hospital of Fushun, Fushun, Liaoning, China

  https://orcid.org/0009-0004-4428-4014

  ⨯